The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway
Abstract
Fibrates modify the expression of genes implicated in lipoprotein and fatty acid metabolism via the peroxisome proliferator-activated receptor alpha(PPARalpha), leading to reductions in serum triglycerides and cholesterol. The expression of certain genes regulated by PPARalpha have been shown to be modified in a species dependent manner. Aspartate aminotransferase (AspAT or GOT) and alanine aminotransferase (AlaAT or GPT) are enzymes involved in intermediate metabolism in all cells and in hepatic gluconeogenesis. These enzymes are also widely used as serum markers of possible tissue damage. This study investigated whether fenofibrate could modify the expression of liver AspAT and/or AlaAT and thus possibly alter transaminase levels independently of a cytotoxic effect. In human Hep G2 cells, fenofibrate increased cytosolic AspAT (cAspAT) activity by 40% and AlaAT activity by 100%, as well as both mRNAs. Nuclear run on assays showed that this effect was, at least in part, transcriptional. Increases in mRNA were also observed in human hepatocyte cultures at concentrations of the drug attained in patients. In C57BL/6 mice, fenofibrate decreased cAspAT and cAlaAT mRNA, while these effects were abolished in PPARalpha knock-out mice. In conclusion, fenofibrate has been shown to modify cAspAT and AlaAT gene expression in a species and PPARalpha dependent manner. This is the first demonstration that cAspAT and AlaAT activities may be pharmacologically altered, independently of a toxic phenomenon.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fibrates are known to increase liver function test values, and the mechanism of this action is attributed to activation of PPARα [85].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [85]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Knowles, B. B., Howe, C. C., & Aden, D. P. (1980) · Science · doi:10.1126/science.6248960 · Cited by 2,025
Ward, A., & Clissold, S. P. (1987) · Drugs · doi:10.2165/00003495-198734010-00003 · Cited by 1,754
Lee, S. S.-T., Pineau, T., Drago, J., Lee, E. J., Owens, J. W., Kroetz, D. L., Fernandez-Salguero, P. M., Westphal, H., & Gonzalez, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.6.3012 · Cited by 1,655
Self-citationControl of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
Schoonjans, K., Staels, B., & Auwerx, J. (1996) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42003-6 · Cited by 1,216
Self-citationThe I.M.A.G.E. Consortium: An Integrated Molecular Analysis of Genomes and Their Expression
Lennon, G., Auffray, C., Polymeropoulos, M., & Soares, M. B. (1996) · Genomics · doi:10.1006/geno.1996.0177 · Cited by 1,123
Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948
Research works printed but not linked: 4
- Cooper, A.J.L., Meister, A., 1985. Metabolic significance of transamination. In: Christen, P., Metzler, D.E. (Eds.), Transaminases, New York, Wiley, pp. 534–563.
- Gugen-Guillouzo, C., Guillouzo, A., 1986. Methods for preparation of adult and fetal hepatocytes. In: Guillouzo, A., Gugen-Guillouzo, C. (Eds.), Isolated and Cultured Hepatocytes, Les Editions INSERM and John Libby Eurotext, pp. 1–12.
- Schmidt, E., Schmidt, F.W., 1985. Aminotransferases in human pathology and clinical chemistry. In: Christen P., Metzler, D.E. (Eds.) Transaminases, Wiley, New York, pp. 587–624.
- Sonderegger, P., Jaussi, R., Christen, P., 1985. Genetics, biosynthesis and intracellular processing of aspartate aminotransferase isoenzymes. In: Christen, P., Metzler, D.E. (Eds), Transaminases, Wiley, New York, pp. 501–510.
Cited by
Peroxisome Proliferator-Activated Receptor Alpha Target Genes
Rakhshandehroo, M., Knoch, B., Müller, M., & Kersten, S. (2010) · PPAR Research · doi:10.1155/2010/612089 · Cited by 1,020
“Studies in mice have shown that PPARα governs metabolism of amino acids by suppressing expression of genes involved in transamination (Aspartate amino transferase (Got1), Alanine amino transferase (Gpt), Alanine glyoxylate aminotransferase (Agtx2), and deamination (Glutaminase (Gls)), as well as numerous genes that ar…”
BackgroundIntegrated physiology and systems biology of PPARα
Kersten, S. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.02.002 · Cited by 670
“[111] Edgar, A.”
The past and present of serum aminotransferases and the future of liver injury biomarkers
McGill, M. R. (2016) · EXCLI journal · doi:10.17179/excli2016-800 · Cited by 487
“This knowledge led to the hypothesis that PPARα regulates expression of ALT and AST, which was supported by the finding that treatment with fenofibrate induced expression of the cytosolic isoforms of both enzymes in human hepatoma cells (Edgar et al., 1998).”
BackgroundInfluentialPrimary biliary cholangitis: pathogenesis and therapeutic opportunities
Gulamhusein, A. F., & Hirschfield, G. M. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0226-7 · Cited by 308
The peroxisome proliferator‐activated receptor α regulates amino acid metabolism
KERSTEN, S., MANDARD, S., ESCHER, P., GONZALEZ, F. J., TAFURI, S., DESVERGNE, B., & WAHLI, W. (2001) · The FASEB Journal · doi:10.1096/fj.01-0147com · Cited by 203
“Although a preliminary link between fibrates and aspartate aminotransferase and alanine aminotransferase has already been made (12), the overall effect of PPARa on amino acid metabolism remains to be established.”
Background
Metadata
- Authors
- Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R.
- Affiliations
- Institut Alfred Fournier (FR)
- Inserm (FR)
- Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR)
- Biopredic (France) (FR)
- Corresponding author
- Edgar, Alan D.
- Venue
- Toxicology Letters
- Publisher
- Elsevier BV
- Published
- 1998-09
- Volume
- 98
- Issue
- 1-2
- Pages
- 13-23
- ISSN
- 0378-4274 (ISSN-L)
- OpenAlex
- W2057906503
- Cited by
- 71
- References
- 45
- Citations by year
- 2026: 1 · 2023: 4 · 2022: 2 · 2021: 3 · 2020: 3 · 2019: 5 · 2018: 2 · 2016: 3 · 2014: 2 · 2013: 2 · 2012: 3
- FWCI
- 0.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Toxicology Letters (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Centre National de la Recherche Scientifique
- Université de Paris
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
- Keywords
- fenofibrate, fibrates, PPARα, aspartate aminotransferase, alanine aminotransferase, hepatic gene regulation, species differences, PPARα knockout mice, HepG2 cells, hepatocytes, drug-induced liver injury
- MeSH terms
- Alanine Transaminase, Transaminases, Animals, Hypolipidemic Agents, Aspartate Aminotransferases, Cells, Cultured, Humans, Liver, Nuclear Proteins, Fenofibrate, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, Blotting, Northern, Gene Expression Regulation, Enzymologic, Receptors, Cytoplasmic and Nuclear, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. https://app.cochat.ai/papers/10.1016/s0378-4274(98)00042-3
- The paper
- Edgar, A. D., Tomkiewicz, C., Costet, P., Legendre, C., Aggerbeck, M., Bouguet, J., Staels, B., Guyomard, C., Pineau, T., & Barouki, R. (1998). Fenofibrate modifies transaminase gene expression via a peroxisome proliferator activated receptor α-dependent pathway. Toxicology Letters. https://doi.org/10.1016/s0378-4274(98)00042-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.